Synergy Pharmaceuticals
Manufacturing · New York, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
420 Lexington Ave Rm 2500, New York, New...Phone Number
(212) 297-0020Website
www.synergypharma.comRevenue
<$5 MillionIndustry
About Synergy Pharmaceuticals
Synergy Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies to treat gastrointestinal diseases and disorders. Its lead product is plecanatide, a novel uroguanylin analog that is traded under the TRULANCE name for the treatment of chronic idiopathic constipation and irritable bowel syndrome. The company also develops dolcanatide to treat mild-to-moderate ulcerative colitis. Synergy Pharmaceuticals Inc. is headquartered in New York, New...Explore more
SIC Code 28,283NAICS Code 32,325Show moreSynergy Pharmaceuticals Org Chart
Compare Similar Companies to Synergy Pharmaceuticals
Compare insights from companies similar to Synergy Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Synergy Pharmaceuticals Tech Stack
A closer look at the technologies used by Synergy Pharmaceuticals
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Synergy Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Synergy Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies to treat gastrointestinal diseases and disorders. Its lead product is plecanatide, a novel uroguanylin analog that is traded under the TRULANCE name for the treatment of chronic idiopathic constipation and irritable bowel s... Read More